Avicanna Announces Results of Annual General and Special Meeting

TORONTO, Oct. 20, 2020 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of cannabinoid-based products, is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated September 22, 2020 were elected as directors of the Company at Avicanna’s annualContinue reading “Avicanna Announces Results of Annual General and Special Meeting”

VIVO Cannabis™ Streamlines Operations

Rightsizing of Napanee Organization Board and Leadership Changes TORONTO, Oct. 20, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“)today announced immediate steps to streamline operations and changes to the Board and Leadership Team. Organizational Rationalization, including an 18% Reduction in Headcount The Company is dedicated to delivering differentiated cannabis products and services while carefully managing expenses,Continue reading “VIVO Cannabis™ Streamlines Operations”

EnWave Announces Normal Course Issuer Bid

VANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the “Company”) today announced that the TSX Venture Exchange (“TSXV”) has accepted the Company’s notice of intention to make a normal course issuer bid. Under the terms of the normal course issuer bid, EnWave may acquire up to 10,918,104 common shares, representingContinue reading “EnWave Announces Normal Course Issuer Bid”

Relevium Resumes Shipments for Overseas Contract and Delivers CAD $215,000 in Formulated Products to Saudi Arabia

MONTREAL, Oct. 19, 2020 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD $215,000 worth of generic formulations to its customer, Innova Health Care based in Saudi Arabia. This represents the second shipmentContinue reading “Relevium Resumes Shipments for Overseas Contract and Delivers CAD $215,000 in Formulated Products to Saudi Arabia”

IGNITE Files Q2 2020 Financial Statements and MD&A

VAUGHAN, Ontario, Oct. 15, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global consumer packaged goods brand, announces that the Company filed its financial statements for the period ended June 30, 2020, interim MD&A for the same period and accompanying certificates (collectively, the “Interim Filings”) today. TheContinue reading “IGNITE Files Q2 2020 Financial Statements and MD&A”

BC Craft Supply Co. Introduces New BC Grown Cultivar From Vodis Pharmaceuticals Inc.

VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE:CRFT) (FSE:ZZD1) is pleased to announce a new and exciting BC cultivar into its supply chain; Meat Breath from Vodis Pharmaceuticals Inc. (“Vodis”) (CSE:VP) (OTC:VDQSF) is a rare and evenly balanced hybrid cannabis strain. This isContinue reading “BC Craft Supply Co. Introduces New BC Grown Cultivar From Vodis Pharmaceuticals Inc.”

SpeakEasy has received Health Canada approval to operate its 53,200 sq ft production and processing facility opening the door to a rapidly growing market

ROCK CREEK, BC, Oct. 13, 2020 /CNW/ – SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the “Company” or “SpeakEasy“) a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, is proud to announce it has received an amendment to its licence to include 13,300 sq ft of its 53,200 sq ft new facility which willContinue reading “SpeakEasy has received Health Canada approval to operate its 53,200 sq ft production and processing facility opening the door to a rapidly growing market”

Aphria Inc. Announces Completion of First EU-GMP Shipment to Germany

Expects first sales of Aphria-branded cannabis in Germany in Q2 FY2021 LEAMINGTON, ON, Oct. 7, 2020 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA) and (Nasdaq: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced it has completed its first certified European Union Good Manufacturing Practices (“EU GMP”) shipmentContinue reading “Aphria Inc. Announces Completion of First EU-GMP Shipment to Germany”

VIVO Cannabis™ Announces Approval of $50 Million Base Shelf Prospectus

TORONTO, Oct. 6, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) announces that it has filed a short form base shelf prospectus (the “Shelf Prospectus“) with securities regulatory authorities in each province of Canada. The Shelf Prospectus will enable the Company to offer common shares, debt securities, convertible securities, subscription receipts, warrants, units or anyContinue reading “VIVO Cannabis™ Announces Approval of $50 Million Base Shelf Prospectus”